Professor Deng Hongkui’s team from the Peking University School of Life Sciences has made the first successful differentiation of human pluripotent stem cells into fully endocrine-subtype-complete islets.
A research team has used multi-emission metal organic framework hydrogel (Eu-Dy MOF gel) to construct a noninvasive wearable eye patch fluorescence sensor, combined with the color recognition function of a smartphone to analyze and monitor lysozyme in tears.
A research team has successfully developed the world’s first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform.
UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective environment—all without the need to customize treatment for each individual patient.
EPFL researchers have developed a powerful method to generate brain-wide, biologically realistic wiring maps of the mouse brain. Their approach bridges experimental data with mathematical and computational modeling to simulate how neurons connect across the entire brain.
An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialized immune cells.
GE HealthCare (Nasdaq: GEHC)+
today announced the launch of Vivid Pioneer, its newest, most advanced cardiovascular ultrasound system.
Abbott (NYSE: ABT)+
announced today that it received CE mark for an expanded indication for its Navitor TAVI system.
The NeuViz P10 uses a cadmium zinc telluride detector to directly convert X-ray photons, thereby eliminating light conversion.